Recurrent myoglobinuria due to carnitine palmitoyltransferase II deficiency: expression of the molecular phenotype in cultured muscle cells

J Neurol Sci. 1996 Mar;136(1-2):178-81. doi: 10.1016/0022-510x(95)00326-w.

Abstract

Carnitine palmitoyltransferase II deficiency (CPT II) is an autosomal recessive disorder and the most frequent cause of hereditary myoglobinuria. We report the case of a young man who presented a severe fever-induced episode of rhabdomyolysis and myoglobinuria resulting in acute renal failure. Cultured skeletal muscle cells have been used for the biochemical and molecular characterization of the defect in this patient. Immunoblot analysis revealed reduced steady-state level of CPT II protein. A PCR-based method detected the common Ser113Leu substitution only in one allele, suggesting that the patient is a compound heterozygote for this common mutation and a different as yet unidentified mutation.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Base Sequence
  • Blotting, Western
  • Carnitine O-Palmitoyltransferase / deficiency*
  • Carnitine O-Palmitoyltransferase / genetics*
  • Cells, Cultured
  • Humans
  • Male
  • Molecular Sequence Data
  • Muscle, Skeletal / enzymology*
  • Myoglobinuria / enzymology*
  • Myoglobinuria / genetics*
  • Phenotype*
  • Polymerase Chain Reaction
  • Recurrence

Substances

  • Carnitine O-Palmitoyltransferase

Grants and funding